Latest filing published 03 Oct 2007 for INTROGEN THERAPEUTICS INC.
No signal scores available.
All filings by James W. Albrecht Jr. on record concern Introgen Therapeutics Inc. In total, 2 filings cover trades dated from 10 January 2006 to 1 October 2007.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 3 October 2007, reports a share grant in Introgen Therapeutics Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations